Does the media prefer RCEL or LMAT?

In the previous week, Avita Medical had 11 more articles in the media than LeMaitre Vascular. MarketBeat recorded 15 mentions for Avita Medical and 4 mentions for LeMaitre Vascular. Avita Medical's average media sentiment score of 0.64 beat LeMaitre Vascular's score of 0.57 indicating that Avita Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avita Medical 4 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LeMaitre Vascular 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ESTA or RCEL?

In the previous week, Avita Medical had 11 more articles in the media than Establishment Labs. MarketBeat recorded 15 mentions for Avita Medical and 4 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.75 beat Avita Medical's score of 0.64 indicating that Establishment Labs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Avita Medical 4 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor INSP or RCEL?

In the previous week, Avita Medical had 14 more articles in the media than Inspire Medical Systems. MarketBeat recorded 15 mentions for Avita Medical and 1 mentions for Inspire Medical Systems. Avita Medical's average media sentiment score of 0.64 beat Inspire Medical Systems' score of 0.55 indicating that Avita Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inspire Medical Systems 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Avita Medical 4 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor KMTS or RCEL?

In the previous week, Avita Medical had 10 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 15 mentions for Avita Medical and 5 mentions for Kestra Medical Technologies. Kestra Medical Technologies' average media sentiment score of 0.74 beat Avita Medical's score of 0.64 indicating that Kestra Medical Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kestra Medical Technologies 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Avita Medical 4 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer RCEL or BFLY?

In the previous week, Avita Medical had 7 more articles in the media than Butterfly Network. MarketBeat recorded 15 mentions for Avita Medical and 8 mentions for Butterfly Network. Avita Medical's average media sentiment score of 0.64 beat Butterfly Network's score of 0.27 indicating that Avita Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avita Medical 4 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Butterfly Network 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Avita Medical (RCEL) Competitors

$15.63 -0.57 (-3.52%)

Closing price 11/13/2026 04:00 PM Eastern

Extended Trading

$15.62 -0.01 (-0.03%)

As of 11/13/2026 07:30 PM Eastern

Compare

RCEL vs. LMAT, ESTA, INSP, KMTS, and BFLY

Should you buy Avita Medical stock or one of its competitors? Avita Medical's main competitors and comparable companies include LeMaitre Vascular (LMAT), Establishment Labs (ESTA), Inspire Medical Systems (INSP), Kestra Medical Technologies (KMTS), and Butterfly Network (BFLY). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Avita Medical compare to LeMaitre Vascular?

Avita Medical (NASDAQ:RCEL) and LeMaitre Vascular (NASDAQ:LMAT) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings.

In the previous week, Avita Medical had 11 more articles in the media than LeMaitre Vascular. MarketBeat recorded 15 mentions for Avita Medical and 4 mentions for LeMaitre Vascular. Avita Medical's average media sentiment score of 0.64 beat LeMaitre Vascular's score of 0.57 indicating that Avita Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avita Medical	4 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LeMaitre Vascular	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Avita Medical presently has a consensus target price of $16.60, indicating a potential upside of 6.21%. LeMaitre Vascular has a consensus target price of $108.25, indicating a potential upside of 38.27%. Given LeMaitre Vascular's higher probable upside, analysts plainly believe LeMaitre Vascular is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
LeMaitre Vascular	0 Sell rating(s)	5 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.38

LeMaitre Vascular has a net margin of 23.51% compared to Avita Medical's net margin of -42.65%. LeMaitre Vascular's return on equity of 15.33% beat Avita Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-42.65%	N/A	-71.34%
LeMaitre Vascular	23.51%	15.33%	9.97%

27.7% of Avita Medical shares are owned by institutional investors. Comparatively, 84.6% of LeMaitre Vascular shares are owned by institutional investors. 2.2% of Avita Medical shares are owned by insiders. Comparatively, 7.4% of LeMaitre Vascular shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

LeMaitre Vascular has higher revenue and earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$71.61M	6.86	-$48.59M	-$1.18	N/A
LeMaitre Vascular	$249.60M	7.18	$57.73M	$2.75	28.47

Avita Medical has a beta of 2.03, suggesting that its stock price is 103% more volatile than the broader market. Comparatively, LeMaitre Vascular has a beta of 0.51, suggesting that its stock price is 49% less volatile than the broader market.

Summary

LeMaitre Vascular beats Avita Medical on 11 of the 16 factors compared between the two stocks.

How does Avita Medical compare to Establishment Labs?

Establishment Labs (NASDAQ:ESTA) and Avita Medical (NASDAQ:RCEL) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, media sentiment, earnings, risk and dividends.

In the previous week, Avita Medical had 11 more articles in the media than Establishment Labs. MarketBeat recorded 15 mentions for Avita Medical and 4 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.75 beat Avita Medical's score of 0.64 indicating that Establishment Labs is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Establishment Labs	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Avita Medical	4 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Avita Medical has lower revenue, but higher earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$211.08M	10.00	-$51.06M	-$1.28	N/A
Avita Medical	$71.61M	6.86	-$48.59M	-$1.18	N/A

Establishment Labs has a net margin of -14.56% compared to Avita Medical's net margin of -42.65%. Avita Medical's return on equity of 0.00% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-14.56%	-196.38%	-10.45%
Avita Medical	-42.65%	N/A	-71.34%

Establishment Labs has a beta of 1.03, indicating that its stock price is 3% more volatile than the broader market. Comparatively, Avita Medical has a beta of 2.03, indicating that its stock price is 103% more volatile than the broader market.

72.9% of Establishment Labs shares are held by institutional investors. Comparatively, 27.7% of Avita Medical shares are held by institutional investors. 10.0% of Establishment Labs shares are held by insiders. Comparatively, 2.2% of Avita Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Establishment Labs presently has a consensus target price of $95.00, suggesting a potential upside of 34.28%. Avita Medical has a consensus target price of $16.60, suggesting a potential upside of 6.21%. Given Establishment Labs' stronger consensus rating and higher possible upside, equities research analysts clearly believe Establishment Labs is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.80
Avita Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Summary

Establishment Labs beats Avita Medical on 10 of the 16 factors compared between the two stocks.

How does Avita Medical compare to Inspire Medical Systems?

Inspire Medical Systems (NYSE:INSP) and Avita Medical (NASDAQ:RCEL) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, valuation, earnings, dividends, media sentiment and profitability.

Inspire Medical Systems has a beta of 0.67, suggesting that its share price is 33% less volatile than the broader market. Comparatively, Avita Medical has a beta of 2.03, suggesting that its share price is 103% more volatile than the broader market.

Inspire Medical Systems currently has a consensus target price of $71.24, suggesting a potential upside of 16.47%. Avita Medical has a consensus target price of $16.60, suggesting a potential upside of 6.21%. Given Inspire Medical Systems' higher probable upside, research analysts plainly believe Inspire Medical Systems is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspire Medical Systems	4 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.05
Avita Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 27.7% of Avita Medical shares are held by institutional investors. 2.2% of Inspire Medical Systems shares are held by company insiders. Comparatively, 2.2% of Avita Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Avita Medical had 14 more articles in the media than Inspire Medical Systems. MarketBeat recorded 15 mentions for Avita Medical and 1 mentions for Inspire Medical Systems. Avita Medical's average media sentiment score of 0.64 beat Inspire Medical Systems' score of 0.55 indicating that Avita Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inspire Medical Systems	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Avita Medical	4 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Inspire Medical Systems has higher revenue and earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspire Medical Systems	$911.98M	1.94	$145.42M	$3.44	17.78
Avita Medical	$71.61M	6.86	-$48.59M	-$1.18	N/A

Inspire Medical Systems has a net margin of 11.43% compared to Avita Medical's net margin of -42.65%. Inspire Medical Systems' return on equity of 7.32% beat Avita Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspire Medical Systems	11.43%	7.32%	6.39%
Avita Medical	-42.65%	N/A	-71.34%

Summary

Inspire Medical Systems beats Avita Medical on 10 of the 17 factors compared between the two stocks.

How does Avita Medical compare to Kestra Medical Technologies?

Kestra Medical Technologies (NASDAQ:KMTS) and Avita Medical (NASDAQ:RCEL) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk and earnings.

In the previous week, Avita Medical had 10 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 15 mentions for Avita Medical and 5 mentions for Kestra Medical Technologies. Kestra Medical Technologies' average media sentiment score of 0.74 beat Avita Medical's score of 0.64 indicating that Kestra Medical Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Kestra Medical Technologies	1 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Avita Medical	4 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Kestra Medical Technologies currently has a consensus price target of $29.00, indicating a potential upside of 1.26%. Avita Medical has a consensus price target of $16.60, indicating a potential upside of 6.21%. Given Avita Medical's stronger consensus rating and higher probable upside, analysts plainly believe Avita Medical is more favorable than Kestra Medical Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kestra Medical Technologies	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50
Avita Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Kestra Medical Technologies has a beta of 0.45, meaning that its stock price is 55% less volatile than the broader market. Comparatively, Avita Medical has a beta of 2.03, meaning that its stock price is 103% more volatile than the broader market.

Avita Medical has a net margin of -42.65% compared to Kestra Medical Technologies' net margin of -140.43%. Avita Medical's return on equity of 0.00% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kestra Medical Technologies	-140.43%	-63.83%	-44.76%
Avita Medical	-42.65%	N/A	-71.34%

27.7% of Avita Medical shares are held by institutional investors. 5.3% of Kestra Medical Technologies shares are held by company insiders. Comparatively, 2.2% of Avita Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Avita Medical has lower revenue, but higher earnings than Kestra Medical Technologies. Avita Medical is trading at a lower price-to-earnings ratio than Kestra Medical Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kestra Medical Technologies	$95.13M	17.93	-$131.61M	-$2.67	N/A
Avita Medical	$71.61M	6.86	-$48.59M	-$1.18	N/A

Summary

Avita Medical beats Kestra Medical Technologies on 9 of the 15 factors compared between the two stocks.

How does Avita Medical compare to Butterfly Network?

Avita Medical (NASDAQ:RCEL) and Butterfly Network (NYSE:BFLY) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, earnings, risk, dividends, profitability and analyst recommendations.

27.7% of Avita Medical shares are owned by institutional investors. Comparatively, 37.9% of Butterfly Network shares are owned by institutional investors. 2.2% of Avita Medical shares are owned by company insiders. Comparatively, 22.0% of Butterfly Network shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Avita Medical had 7 more articles in the media than Butterfly Network. MarketBeat recorded 15 mentions for Avita Medical and 8 mentions for Butterfly Network. Avita Medical's average media sentiment score of 0.64 beat Butterfly Network's score of 0.27 indicating that Avita Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avita Medical	4 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Butterfly Network	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Avita Medical has a beta of 2.03, meaning that its share price is 103% more volatile than the broader market. Comparatively, Butterfly Network has a beta of 2.16, meaning that its share price is 116% more volatile than the broader market.

Avita Medical has a net margin of -42.65% compared to Butterfly Network's net margin of -43.56%. Avita Medical's return on equity of 0.00% beat Butterfly Network's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-42.65%	N/A	-71.34%
Butterfly Network	-43.56%	-21.60%	-14.25%

Avita Medical has higher earnings, but lower revenue than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$71.61M	6.86	-$48.59M	-$1.18	N/A
Butterfly Network	$97.61M	16.65	-$77.06M	-$0.21	N/A

Avita Medical presently has a consensus target price of $16.60, indicating a potential upside of 6.21%. Butterfly Network has a consensus target price of $8.75, indicating a potential upside of 44.03%. Given Butterfly Network's stronger consensus rating and higher possible upside, analysts clearly believe Butterfly Network is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Butterfly Network	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.75

Summary

Butterfly Network beats Avita Medical on 10 of the 16 factors compared between the two stocks.

Get Avita Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RCEL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RCEL vs. The Competition

Export

Metric	Avita Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$509.01M	$5.96B	$7.84B	$12.19B
Dividend Yield	N/A	1.68%	2.46%	4.53%
P/E Ratio	-13.25	38.39	34.71	28.44
Price / Sales	6.86	5.57	8.66	5.84
Price / Cash	N/A	23.95	21.93	22.49
Price / Book	-15.79	4.45	4.35	3.76
Net Income	-$48.59M	$143.14M	$3.51B	$390.55M
7 Day Performance	-5.79%	-1.25%	-1.49%	-0.33%
1 Month Performance	19.31%	-1.30%	-2.55%	-4.82%
1 Year Performance	316.80%	1.73%	0.92%	-5.83%

Avita Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RCEL Avita Medical	1.7593 of 5 stars	$15.63 -3.5%	$16.60 +6.2%	+317.9%	$509.01M	$71.61M	N/A	226	News Coverage Analyst Forecast
LMAT LeMaitre Vascular	4.5964 of 5 stars	$81.74 +0.6%	$110.60 +35.3%	-12.7%	$1.87B	$262.43M	28.71	655
ESTA Establishment Labs	3.3512 of 5 stars	$62.00 +1.5%	$95.00 +53.2%	+9.3%	$1.85B	$264.03M	N/A	1,004
INSP Inspire Medical Systems	3.8452 of 5 stars	$62.13 -7.6%	$70.94 +14.2%	-29.5%	$1.79B	$911.98M	13.43	1,333	Analyst Downgrade Gap Down
KMTS Kestra Medical Technologies	1.2613 of 5 stars	$30.08 +0.9%	$29.00 -3.6%	+15.0%	$1.79B	$106.73M	N/A	443

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RCEL) was last updated on 11/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Avita Medical (RCEL) Competitors

RCEL vs. LMAT, ESTA, INSP, KMTS, and BFLY

How does Avita Medical compare to LeMaitre Vascular?

Summary

How does Avita Medical compare to Establishment Labs?

Summary

How does Avita Medical compare to Inspire Medical Systems?

Summary

How does Avita Medical compare to Kestra Medical Technologies?

Summary

How does Avita Medical compare to Butterfly Network?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RCEL vs. The Competition

Avita Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Avita Medical (RCEL) Competitors

RCEL vs. LMAT, ESTA, INSP, KMTS, and BFLY

How does Avita Medical compare to LeMaitre Vascular?

Does the media prefer RCEL or LMAT?

Do analysts recommend RCEL or LMAT?

Is RCEL or LMAT more profitable?

Do institutionals & insiders have more ownership in RCEL or LMAT?

Which has stronger valuation & earnings, RCEL or LMAT?

Which has more risk and volatility, RCEL or LMAT?

Summary

How does Avita Medical compare to Establishment Labs?

Does the media favor ESTA or RCEL?

Which has higher valuation & earnings, ESTA or RCEL?

Is ESTA or RCEL more profitable?

Which has more volatility & risk, ESTA or RCEL?

Do insiders & institutionals have more ownership in ESTA or RCEL?

Do analysts prefer ESTA or RCEL?

Summary

How does Avita Medical compare to Inspire Medical Systems?

Which has more volatility and risk, INSP or RCEL?

Do analysts prefer INSP or RCEL?

Do insiders and institutionals have more ownership in INSP or RCEL?

Does the media favor INSP or RCEL?

Which has preferable earnings and valuation, INSP or RCEL?

Is INSP or RCEL more profitable?

Summary

How does Avita Medical compare to Kestra Medical Technologies?

Does the media favor KMTS or RCEL?

Do analysts recommend KMTS or RCEL?

Which has more volatility and risk, KMTS or RCEL?

Is KMTS or RCEL more profitable?

Do insiders & institutionals believe in KMTS or RCEL?

Which has stronger valuation and earnings, KMTS or RCEL?

Summary

How does Avita Medical compare to Butterfly Network?

Do institutionals and insiders have more ownership in RCEL or BFLY?

Does the media prefer RCEL or BFLY?

Which has more risk and volatility, RCEL or BFLY?

Is RCEL or BFLY more profitable?

Which has preferable earnings & valuation, RCEL or BFLY?

Do analysts rate RCEL or BFLY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RCEL vs. The Competition

Avita Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools